Why Medifast, Inc.’s (MED) Stock Is Up 5.53%
As of Friday, August 07, Medifast, Inc.’s MED share price has surged by 5.53%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Cynthia McLaughlin
Omar Beirat
Rosalio Madrigal
Michael Rose
Michael Rose
| Share Statistics | MED | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $120.1 | $250.9 | 23% |
|
| Shares Out (Mil) | 11.1 | 27.3 | 22% |
|
| Institutional Ownership | 93.9% | 50.0% | 64% |
|
| Float (Mil) | 8.5 | 33.2 | 17% |
|
| Beta | 0.70 | 0.64 | 41% |
|
| Avg Daily Volume (000s) | 110 | 147 | 36% |
|
| Price Change (52-week) |
(17.9%) | 55.2% | 31% |
|
| Growth | MED | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (16.2%) | 1.8% | 3% |
|
| Net Income (5yr) | (16.9%) | (4.8%) | 23% |
|
| EPS (5yr) | (17.0%) | 2.3% | 16 |
|
| Dividends (5yr) | (14.9%) | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.1%) | (14.9%) | 51% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.350) | ($1.150) | ($0.280) | |
| Month Ago EPS | ($0.620) | ($1.850) | ($0.600) | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.620) | ($1.850) | ($0.600) | |
| Year/Year Chg | 25.0% | (32.4%) | na | |
| Financials | MED | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $317 | $417 | 36% |
|
| Net Income (TTM) (Mil) | ($26) | ($5) | 22% |
|
| EPS (TTM) | ($2.321) | ($0.100) | 13% |
|
| Operating Cash Flow (TTM) (Mil) | $9 | $16 | 38% |
|
| Net Cash Flow (TTM) (Mil) | ($30) | $3 | 23% |
|
| Long-Term Debt (Q1) (Mil) | $23 | $43 | 33% |
|
| Enterprise Value (Q1) (Mil) | ($22) | $302 | 1% |
|
| Valuation | MED | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.61 | 1.66 | 10% |
|
| P/E | na | 15.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.6 | na |
|
| Ratios | MED | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 69.2% | 64.2% | 80% |
|
| Net Margin | (8.1%) | 1.2% | 22% |
|
| ROA | (9.7%) | (1.5%) | 26% |
|
| ROE | (12.4%) | 1.0% | 27% |
|
| Liabilities to Assets | 24.6% | 48.8% | 17% |
|
| F-Score | 3 | 4 | 18% |
|
Medifast, Inc. did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors